Notice: This company has been marked as potentially delisted and may not be actively trading. ARCA biopharma (ABIO) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for ARCA biopharma (NASDAQ:ABIO)CurrentInstitutional OwnershipPercentage56.44%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$12.12BNumber ofInstitutional Sellers(last 12 months)0 Get ABIO Insider Trade Alerts Want to know when executives and insiders are buying or selling ARCA biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABIO Institutional Buying and Selling by Quarter ARCA biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails9/16/2024Cubist Systematic Strategies LLC27,779$106K0.0%N/A0.191% 8/16/2024Perceptive Advisors LLC15,507,760$59.40M1.4%N/A106.898% 8/16/2024Driehaus Capital Management LLC3,846,150$14.73M0.1%N/A26.512% 8/15/2024Affinity Asset Advisors LLC72,484$278K0.0%N/A0.500% 8/14/2024Cubist Systematic Strategies LLC27,779$106K0.0%N/A0.191% 8/9/2024Renaissance Technologies LLC73,099$280K0.0%+11.3%0.504% 8/7/2024Cowen AND Company LLC700,000$2.68M0.1%N/A4.825% 2/20/2024Cable Car Capital LLC4,000,452$6.80M7.6%N/A27.589% 1/31/2024abrdn plc32,461$55K0.0%N/A0.000% 11/14/2023Newtyn Management LLC300,000$603K0.1%-4.2%0.000% Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 4/14/2023BML Capital Management LLC706,930$1.41M1.2%-17.6%0.000% 2/13/2023BML Capital Management LLC858,256$2.03M1.9%N/A5.956% 2/10/2023Murchinson Ltd.50,593$120K0.0%N/A0.351% 11/7/2022Virtu Financial LLC14,221$29K0.0%N/A0.099% 7/27/2022Bailard Inc.35,000$87K0.0%N/A0.243% 4/26/2022 Marquette Asset Management LLC17,318$40K0.0%N/A0.120% 2/10/2022Acadian Asset Management LLC57,822$123K0.0%N/A0.401% 11/15/2021GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067% 11/15/2021Minerva Advisors LLC10,000$30K0.0%N/A0.069% 11/9/2021BlackRock Inc.268,394$795K0.0%-1.8%1.863% 8/16/2021State Street Corp69,037$241K0.0%N/A0.479% 8/13/2021Geode Capital Management LLC87,659$305K0.0%+10.7%0.608% 8/13/2021Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765% 8/12/2021XTX Topco Ltd10,846$38K0.0%N/A0.075% 8/5/2021GSA Capital Partners LLP130,395$455K0.1%+39.8%0.905% 5/19/2021Virtu Financial LLC16,655$61K0.0%-32.4%0.116% 5/17/2021PDT Partners LLC17,297$63K0.0%N/A0.120% 5/12/2021Geode Capital Management LLC79,151$288K0.0%+141.7%0.549% 5/10/2021GSA Capital Partners LLP93,241$340K0.1%+102.3%0.647% 2/24/2021Virtu Financial LLC24,641$99K0.0%N/A0.264% 2/10/2021Renaissance Technologies LLC205,500$824K0.0%+436.4%2.205% 2/10/2021Panagora Asset Management Inc.6,878$28K0.0%N/A0.074% 2/4/2021GSA Capital Partners LLP46,097$185K0.0%N/A0.495% (Data available from 1/1/2016 forward) ABIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABIO shares? During the previous two years, 11 institutional investors and hedge funds held shares of ARCA biopharma. The most heavily invested institutionals were Perceptive Advisors LLC ($59.40M), Driehaus Capital Management LLC ($14.73M), Cable Car Capital LLC ($6.80M), Cowen AND Company LLC ($2.68M), BML Capital Management LLC ($1.41M), Newtyn Management LLC ($603K), and Renaissance Technologies LLC ($280K).Learn more on ABIO's institutional investors. What percentage of ARCA biopharma stock is owned by institutional investors? 56.44% of ARCA biopharma stock is owned by institutional investors. Learn more on ABIO's institutional investor holdings. Which institutional investors have been buying ARCA biopharma stock? Of the 10 institutional investors that purchased ARCA biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($15.51M), Cable Car Capital LLC ($4.00M), Driehaus Capital Management LLC ($3.85M), BML Capital Management LLC ($858.26K), Cowen AND Company LLC ($700K), Affinity Asset Advisors LLC ($72.48K), and Cubist Systematic Strategies LLC ($55.56K). How much institutional buying is happening at ARCA biopharma? Institutional investors have bought a total of 25,131,114 shares in the last 24 months. This purchase volume represents approximately $12.43B in transactions. Which ARCA biopharma major shareholders have been selling company stock? The following institutional investors have sold ARCA biopharma stock in the last 24 months: BML Capital Management LLC ($151.33K), and Newtyn Management LLC ($13.20K). How much institutional selling is happening at ARCA biopharma? Institutional investors have sold a total of 164,526 shares in the last 24 months. This volume of shares sold represents approximately $47.18M in transactions. Related Companies Telomir Pharmaceuticals Major Shareholders Caribou Biosciences Major Shareholders Instil Bio Major Shareholders 2seventy bio Major Shareholders Sagimet Biosciences Major Shareholders Cabaletta Bio Major Shareholders Cassava Sciences Major Shareholders Seres Therapeutics Major Shareholders Solid Biosciences Major Shareholders TScan Therapeutics Major Shareholders This page (NASDAQ:ABIO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABIO Stock Alerts